Sampling is a fundamental component of disease assessment, but how to sample is no trivial matter. Even with simple random sampling, there is still the question of how many samples should be taken. In developing a sampling plan, one has to balance several factors, which can be broadly categorized into cost, precision, and goal. Cost includes all factors related to the site selection (e.g., fields), sample selection within sites, time (travel to sites, sample procurement, and processing), and labor involved. Added costs include materials associated with serological or molecular diagnostic tools in situations where disease assessments are not made visually. Precision of disease assessment estimates is related to the goal of sampling. For example, researchers may require fairly precise estimates of disease in designed experiments comparing the effects of treatments. Precision requirements may be lower if the goal of sampling is to determine whether disease is below or above some decision-triggering threshold, or could be much higher in the immediate region of the actual threshold (10) .
The suitability of a sampling scheme is impacted by the characteristics of the particular crop and disease under study. Snap bean (Phaseolus vulgaris L.) crops are sown in relatively large field blocks (>2 ha) at high plant densities (about 43 plants per m 2 ). Here, sparse sampling for disease assessment is a necessity, in that incidence estimates inferred to the whole field will be made from a relatively small sample of the plant population within that field. With virus-induced plant diseases, incidence is in many situations much easier to assess than severity. Even so, plants may be infected but asymptomatic (literature citation 22 is an example). Therefore, disease incidence assessed visually may drastically underestimate the true incidence of virus-infected plants (22) . In such instances, serological or molecular-based virus diagnostic techniques, though obviously more costly, are far more reliable than visual assessments. Cost then becomes a significant concern and limiting factor, and one then has to balance the cost of sampling against the quality of the information derived. If serological or molecular-based diagnostic techniques are the methods of choice for assessing disease incidence, then the most practical approach is to collect all samples from a given field (or plot) at the same time, because it is most efficient to process several samples simultaneously back in the laboratory. Sequential sampling schemes (10) are therefore not attractive from a logistical standpoint.
There is growing evidence that many plant diseases are not distributed randomly in the spatial sense, but occur as aggregates of infected individuals (3, 17, 26 provide recent examples), and this is also true of aphid-transmitted viruses (2, 4, 11) . A sampling scheme for assessing the incidence of virus-infected plants therefore should account for the inherent spatial properties of the disease. Recently, there have been seminal advancements in the theory of sampling and estimation of plant disease incidence (6, 9, 10, 12) , and the results are finding their way into practical sampling plans (4, 23, 24) . In this paper, we draw on this recent theoretical work to demonstrate how spatial pattern information is incorporated into a sampling framework for ascertaining the incidence of infection by the aphid-transmitted viruses Alfalfa mosaic virus (AlMV) and Cucumber mosaic virus (CMV) in processing snap bean.
MATERIALS AND METHODS
Six early-planted and six late-planted snap bean fields in western New York were sampled in 2002 and 2003. Early plantings occurred from late May through the end of the first week of June, whereas late plantings occurred during the first half of July. Sampled fields are described in more detail elsewhere (14, 19) . Sampling was done when the fields were at the bloom or early pin stage. In each field, 16 quadrats were indiscriminately sampled, each quadrat consisting of five adjacent plants. This is a form of cluster sampling. Plants were tested for the presence of AlMV and CMV as previously described (19) .
Binary power law. Spatial pattern analysis had indicated that plants infected by AlMV or CMV could be aggregated within fields (19) , and therefore the level of aggregation should be accounted for in a sampling plan for determining virus incidence. The binary power law (5) is useful for quantifying the relationship between aggregation and incidence, because the extent of aggregation could change with the incidence of infected plants (2, 4, 17, 18, 23) .
The proportion of virus-infected plants (x) in a sampled quadrat is given by x = X/n, where X is the number of infected plants out of n sampled plants in the quadrat. If c is the observed variance in x in a given field, and p low is the proportion of infected plants in the field, then the binary power law
specifies a linear relationship between c and p low , where ln(Ψ) is the natural logarithm of Ψ. The parameters A and b can be estimated by linear regression, and their interpretation is discussed in detail elsewhere (10) . There were 24 data points available for each virus. We fit the binary power law to the data for each virus (AlMV and CMV) separately and also to the combined data set, using SAS Proc REG (SAS Institute, Cary, NC 
where C is the ratio of the standard error of loŵ p (i.e., se
. The parameters of the binary power law fitted to the combined data set were used in equation 2 to estimate the number of quadrats required to achieve specified levels of precision in loŵ p for quadrats of size n = 5. Group testing for estimating incidence. Testing samples individually may not be as efficient as testing groups of plants and then estimating the incidence of infection from the results on the grouped samples. This method, termed group testing, has found application in plant pathology (16, 20) . So-called hierarchical sampling (6) is a form of group testing conditioned on sampling within a spatial hierarchy. Assume that all samples from a given quadrat are bulked into one sample for that quadrat and then tested by serology. Let p high represent the incidence of quadrats that were positive for virus infection in the same field. Also, assume the number of virus-infected plants per quadrat is described by the beta-binomial probability distribution, which has now been shown to fit disease incidence data very well (references cited within literature citation 9), and which is a way of accounting for the aggregation of infected plants. The relationship between p low and p high is then described by (3) where Π is the product function, i indexes integers from 0 to n -1, and θ is the aggregation parameter of the beta-binomial distribution. The subscript E on p high,E signifies that this is an exact estimate of p high , assuming that the beta-binomial distribution fully describes the data. If the binary power law applies, then (4) reflecting the variation of θ with p low (9) . Equation 3 is not amenable to rearrangement to allow the prediction of p low from p high , except for n = 2 or n = 4 (6). An alternative expression for the relationship between p low and p high is (5) in which v is a parameter representing the so-called effective sample size (9 
The subscript v on p low,v indicates that this estimate of p low depends on the parameter v. It is clear from equations 5 and 6 that an exact expression for v can be derived, but it will be a function of p low , which is not a desirable property for predicting p low from p high in equation 6. However, a reasonable estimate of v can be obtained empirically. We used a two-step approach in doing so.
Step 1. CLL(p) is called the complementary log-log transformation of p, and is given by CLL(p) = ln[-ln(1 -p)]. The relationship between p low and p high can then be described by
where the subscript on v indicates that the parameter v is estimated from the CLL relationship between p low and p high . Equation 7 was used to obtain a first estimate and possible range (the 95% profile likelihood function-derived confidence interval) for v CLL . Equation 7 specifies an intercept of ln(1/v CLL ) and slope = 1. The intercept was estimated using SAS Proc GENMOD with link=identity, dist=normal, and offset=CLL(p high ) options in the model statement. The estimate of v CLL obtained this way serves only as a general starting point; the CLL relationship based on the beta-binomial distribution is not strictly a straight line, but exhibits curvature at higher values of p low (9) . However, the curvature at higher values of p low is obvious only at relatively large values of θ. We did not discern any curvature in a CLL(p low ):CLL(p high ) plot of our data (data not shown).
Step 2. The absolute difference between p high,E and p high,v (i.e., ⏐p high,E -p high,v ⏐) is a function of both p low and v. To further refine the primary estimate v CLL , we constructed a three-dimensional plot of ⏐p high,E -p high,v ⏐ versus p low and v, with the 95% confidence interval for v CLL as a starting point. This plot was used to obtain a narrower parameter space for v (i.e., [v 1 , v 2 ]) which appeared to minimize ⏐p high,E -p high,v ⏐. We then calculated (by numerical integration) and plotted ∫
The integration was done over the range [0, 0.6] for p low because there was not much further change in p high,E for p low > 0.6 (for which p high,E = 0.964). The optimal value for v (v opt ) was that value of v which minimized the integrand.
Sampling effort and confidence interval widths. Upper and lower confidence interval points for p low were obtained by first calculating the respective limits for p high and then using the monotonic relationship between p low and p high over [0, 1] for fixed v (21) . The upper and lower confidence limits for p high were calculated using the Wilson score interval which, when applied at the group level, generally provides coverage for p low closest to the nominal level compared with other methods for determining confidence intervals (21) . If t is the number of quadrats positive for virus infection out of the N quadrats sampled, then the Wilson interval is given by
where z 1-α/2 is the 1 -α/2 quantile of the standard normal distribution. p low was plotted as a function of p high for v opt and for when v = n (using equation 6), along with their respective upper and lower confidence limits (equation 8).
Equations 6 and 8 were used to estimate the width of the confidence interval for p low when N = 16 and n = 5, reflecting the sampling scheme we used in 2003 and 2004. One may question whether increasing the sampling effort, in terms of the number of quadrats sampled, pays off in terms of an appreciable increase in the confidence of the estimate of p low (i.e., a smaller confidence interval width for p low ) when group testing is used. To address this question, equations 6 and 8 were used to derive an expression for the confidence interval width of p low (CI low ) as a function of p low and N. Suppressing the subscripts on z for simplicity, CI low is given by
Equation 9 was used to plot CI low as a function of p low for fixed values of N and v = v opt .
Rate of change in the confidence interval width. Although increasing the number of quadrats sampled leads to more precise estimates of p low , there may be a point at which further increases in N lead to only marginal reductions in CI low , which may not justify the sampling effort and cost. We therefore calculated and plotted the second partial derivative of CI low with respect to N (i.e., ∂ 2 CI low /∂N 2 ) against N for different fixed values of p low . The expression for ∂ 2 CI low /∂N 2 is rather long and is not given here. This plot represents how much the rate of change of CI low depends on N at different p low .
Group versus individual testing. An important decision is whether to individually test all n·N samples, or use group testing and then estimate p low from p high . Although group testing is less costly in terms of labor and reagents, it can be more costly if the confidence intervals for p low are wider than one is willing to accept. One way of addressing the question is to determine the minimum number of quadrats to sample so that the confidence interval width for p low is at least equal to that obtained by testing each of the n·N samples individually. This was done by solving CI diff = 0 for N, where CI diff is the difference in the confidence interval widths for the estimate of incidence obtained by individual and group testing. Aggregation of virus-infected plants within quadrats was accounted for by using v = v opt in equation 9 when calculating CI low .
The Wald-based confidence interval ( loŵ p ± z 1-α/2 ·se[ loŵ p ]) is the simplest method for calculating an associated confidence interval for the estimate of the incidence of virus-infected plants (10) . Although the Wald interval is widely used, there is now For our data, the maximum difference between se a ( loŵ p ) and se r ( loŵ p ), which occurs at p low = 0.5, was 0.0079. The Jeffreys interval approximation as used here is also computationally more feasible than exact confidence interval methods based on the betabinomial distribution (25) .
RESULTS
Binary power law. The binary power law was a good descriptor of the relationship between the observed and theoretical (binary) variance in the proportion of virus-infected plants per quadrat, for both AlMV and CMV (Table 1) . Confidence intervals for the slope (b) and intercept [ln(A)] parameters for each virus overlapped, so the data sets were combined and treated as one. For the combined data, b was >1 (but only slightly) and ln(A) was >0 (A = 1.762), which meant that the degree of aggregation varied with p low systematically (10) . For p low in the range [0.01, 0.5], θ (estimated from equation 4) was between 0.069 and 0.142.
Sampling for precision. Figure 1 shows the number of quadrats that should be sampled to achieve specified precision levels in the estimates of p low . It is clear that for C = 0.1, N becomes prohibitively large (from a practical standpoint) for p low < 0.2. One could relax the stringency on the required precision levels, and so reduce the number of quadrats to be sampled. However, N is still quite large for precision levels given by C = 0.1 or 0.2 for estimating incidence levels below 0.1 (Fig. 1) . (Fig. 2A) . Using Figure 2A, (Fig. 2B) . It was apparent from the shape of the curves with respect to v in Figure 2B that a decision criterion would have to be established concerning the range of p low for which p high,E -p high,v should be minimized. We chose to minimize ⏐p high,E -p high,v ⏐ over p low ∈ [0, 0.6] because there was not much further change in p high,E for p low > 0.6 (i.e., p high,E ≈ 1). The value of v which minimized ∫ 6 . 0 0 ⏐p high,E -p high,v ⏐dp low over v ∈ [3.80, 4.00] was v opt = 3.903 (Fig. 2C) , which gave a close match between p high,v and p high,E (Fig. 2D) .
The parameter value v opt was used in equation 6, which together with equation 8 was used to plot p low as a function of p high (Fig. 3) . Explicitly accounting for aggregation of virus-infected plants was apparent in the p low :p high curve (the v = v opt curve is above that for v = n), becoming more so as p high increased. Confidence interval limits were shifted as well, more noticeably for the upper confidence limit (Fig. 3) .
Sampling effort and confidence interval widths. It is apparent from Figure 3 that estimating p low from p high by group testing when N = 16 results in a confidence interval width CI low that is rather large when p low is >0.1. Sampling more quadrats (i.e., increasing N) may reduce CI low . Increasing N had the biggest impact on CI low at the higher levels of p low (Fig. 4) ; for p low < 0.1, the reductions in CI low were marginal for N in the range [16, 60] .
Rate of change in the confidence interval width. For different values of p low , ∂ 2 CI low /∂N 2 decreased in an exponential-like manner with increasing N (Fig. 5) . The largest changes in ∂ 2 CI low /∂N 2 were observed up to about N = 40 (Fig. 5 ). For N ∈ [40, 60], the changes in ∂ 2 CI low /∂N 2 were smaller. This suggests that sampling N > 40 quadrats may not provide enough gains in the confidence of the estimate of p low to offset the added costs in sampling and sample processing. A sampling effort of N = 40 may be a reasonable sample size for estimating p low from p high .
Group versus individual testing. The above result suggested that N = 40 may be a reasonable upper limit on sampling effort for estimating p low from p high (corresponding to n·N = 200 plants). However, compared with testing 200 plants individually, it can be seen (Fig. 6A) that, even at low incidences of plant infection (i.e., p low < 0.1), more than 40 groups would have to be tested to Fig. 1 . Number of quadrats (N) required to achieve a desired level of precision, as specified by the coefficient of variation of the mean (C), in relation to the incidence of virus-infected snap bean plants. Calculations are based on parameter estimates derived from the binary power law relationship (Table 1) and used in equation 2. In terms of the number of tests that need to be done, group testing will require less serological assays up to about p low = 0.5. For higher incidences of plant infection, many more groups would need to be tested for attaining CI low ≤ ) ( low CI p J (Fig. 6A) . This result can also be shown for other choices of n·N. Figure 6A suggested that for p low < 0.5 one could achieve CI low ≤ ) ( low CI p J by group testing on Q G < n·N quadrats, where Q G is the number of quadrats assayed by group testing. In Figure 6B, (Fig. 6B) . However, the graph did suggest that for this particular sampling plan group testing when p low was ≤0.2 provided as precise estimates as individual sampling, at a far lower investment in testing resources.
DISCUSSION
Aphid-transmitted viruses and the diseases they induce are an emerging problem in processing snap bean in the Midwest and Northeast regions of the United States (7). As researchers begin to understand which viruses are the major components of the disease complex, efforts will begin to shift from basic assessments of prevalence to more detailed disease assessment surveys, including also designed experiments on basic epidemiology and likely disease mitigation strategies. Researchers will thus fairly soon require sampling guidelines for assessing virus intensity in snap beans.
Disease incidence is much easier and practical to assess than severity for virus-induced diseases in snap bean, especially in routine field assessments. In this paper, we demonstrate how a sampling plan for the incidence of aphid-transmitted viruses (AlMV and CMV) can be developed from an underlying understanding of the spatial pattern of virus-infected plants in commercial fields. Data on the incidence of snap bean infection by AlMV and CMV collected over two field seasons could be combined into one data set. The conformance in the observed spatial patterns suggests common spatial generative processes via viral transmission and spread in snap bean. Our sampling plan analysis may therefore be extended to provide a generalized basis for the sampling of other aphid-transmitted viruses in snap bean, but not without caution however. Several non-colonizing aphid species disperse throughout snap bean fields during the course of the season (14) , and there may be differences in the viruses they vector as well as in transmission efficiencies. The influence of these factors could lead to different levels of aggregation of virus-infected plants, as observed with Citrus tristeza virus (4) .
Estimating the incidence of virus infection at low incidences of infection by testing plants individually is prohibitive in terms of the number of samples and associated cost of the required serological tests (our experience has been that the average cost of assaying one sample in duplicate by serology is US$1.30), for any reasonable specified precision (C = 0.1, 0.2). Given the rather large sample sizes required at low infection incidences, it may be more practical and economical to instead use group testing (16, 20) . The incidence of plant infection (p low ) is then estimated from incidence at the group level (p high ). The relationship between p low and p high derived from the binomial distribution is a wellknown function in group testing (equation 6 with v = n), but applies only if infected plants are spatially random when sampling is done within a spatial hierarchy (e.g., snap bean plants within quadrats). However, as we have shown in this paper, AlMV-and CMV-infected snap bean plants are spatially aggregated, and the level of aggregation changes with mean incidence systematically. Therefore, in order to estimate p low from p high , one must use an expression relating p high to p low that accounts for the underlying spatial aggregation. Aggregation at the individual plant level can be described by the beta-binomial distribution (8) , but this leads to a mathematically intractable functional relationship between p low and p high (6) . The problem spurred research into finding approximate empirical functions for describing the p low :p high relationship (9) . We used this approach to derive an empirical relationship between p low and p high for virus-infected snap bean. Note that the spatial aggregation is nested (via the parameter v = v opt ) within the statistical relationship between p high and p low , in that group testing has to be performed on groups comprising all n samples collected from within one quadrat. That is, the empirical p low :p high relationship derived here is invalid if samples are randomly grouped for testing after collection. Sampling then necessarily involves more extensive sample tracking in the field and during processing in the lab, but in our experience does not unreasonably increase time and effort invested.
Our preference was for using confidence intervals (rather than standard errors) to convey information on the precision of disease incidence estimates. Confidence intervals not only carry information on precision, but simultaneously represent magnitude and shifts in coverage as well. For example, explicitly accounting for aggregation modifies the confidence interval endpoints for p low when estimated from p high , as seen in Figure 3 . Confidence intervals for proportions (such as disease incidence) can be poor in their coverage probability (that is, not meet the nominal 1-α level) due to the inherent discreteness and skewness in the underlying probability distributions (binomial, beta-binomial, or other) (1,15) . It was recently shown that the common Wald interval provides erratic coverage even for large sample sizes and for p low not close to 0 or 1 (1) . In this study, we used confidence interval estimators that have already been investigated in terms of their properties (1, 21) . These intervals are approximate, but are an acceptable alternative to the more computationally intensive calculation of exact intervals. Additionally, their closed forms make for easier graphically based investigations. Though we justified approximating se a ( loŵ p ) with se r ( loŵ p ) in the calculation of confidence intervals for loŵ p , this will not be reasonable in all situations, and there is the need for further work on appropriate confidence intervals for loŵ p when disease is aggregated (13) . Although one can use the p low :p high relationship to predict p low from p high , there is a trade-off in terms of wider confidence intervals for p low when estimated from p high , especially as p high increases. The confidence interval width can increase to the point where it may be deemed unacceptable, depending on the project's goals. Confidence interval widths can be decreased by increasing the sampling effort, but one can question whether the increased costs of further sampling are offset by appreciable gains in confidence interval width reduction. We showed that increasing the number of quadrats sampled and tested (at the group level) can be a very effective means of reducing the confidence interval width for p low , more so at higher incidences of plant infection. However, the gains in confidence interval width reduction are probably not worth the increased sampling costs after about N = 40 in this particular study, because the rate of reduction may not keep pace with the increased cost of sampling.
Another approach is to determine the number of groups that ought to be tested so that the respective confidence interval widths derived from group and individual testing are the same. The question is whether the number of serological tests can be reduced by using group testing, without sacrificing precision in the estimates of incidence. For example, we showed that for a sampling plan consisting of n·N = 200 plants tested individually, the same precision can be obtained with group testing with N G = 60, up to about p low = 0.2. Above that, the confidence interval width for p low obtained via group testing diverged markedly from the width obtained from the testing of individual plants. For the sampling scheme under consideration at this point (N = 60, n = 5), our results suggest using group testing until p high is in the range [0.35, 0.59], for which the corresponding range in p low is [0.1, 0.2]. loŵ p is a biased estimator of p low when derived from the p low :p high relationship (20) . We did not explicitly address the bias of loŵ p in this paper, but it is relatively small in the present context. For the sampling plan consisting of N G = 60, n = 5, we calculated the bias in loŵ p to be 0.0008 when p low = 0.1, and 0.002 when p low = 0.2. If the incidence of virus-infected plants is expected to be higher subsequently, then testing at the individual plant level is more precise, from a confidence interval point of view.
The analysis we present in this paper shows that there are upper practical limits for sample sizes in assessing the incidence of virus-infected plants in snap bean fields, and that the return on additional sampling (increased precision) may not be justified by the higher labor and material costs involved. We hope that the approach presented here will be useful to other groups studying aphid-transmitted viruses, in snap bean or in other vegetable crops. We are continuing our studies on the aphid-snap bean-virus complex by examining the temporal progression of virus incidence, and for this a combination of group testing (at the early stages of an epidemic) followed by individual testing at the later stages of the epidemic will be used, as suggested by the analyses presented in this paper.
